Weiss Multi-Strategy Advisers’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RA
Weiss Multi-Strategy Advisers's HAE Position: Q1 2024 in Review
Weiss Multi-Strategy Advisers sold out of Haemonetics (HAE) in Q1 2024, closing a stake of 26,690 shares — an estimated $2.28M sold.
Weiss Multi-Strategy Advisers first reported a position in HAE in Q3 2013 and held it in 16 quarters. The position peaked at $3.42M in Q1 2023. 298 funds tracked by Wall St. Rank hold HAE as of Q1 2024.
- Weiss Multi-Strategy Advisers reported no remaining Haemonetics position as of Q1 2024 after selling out during the quarter.
- Weiss Multi-Strategy Advisers sold 26,690 Haemonetics shares in Q1 2024, an estimated $2.28M.
- Weiss Multi-Strategy Advisers first reported a position in Haemonetics in Q3 2013 and held it in 16 quarters.
- Weiss Multi-Strategy Advisers's Haemonetics position peaked at $3.42M in Q1 2023.
- 298 funds tracked by Wall St. Rank held Haemonetics as of Q1 2024.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.